{"title":"静脉注射脂肪在外科病人中的临床应用。","authors":"W. Marshall","doi":"10.1097/00006534-195910000-00030","DOIUrl":null,"url":null,"abstract":"An intravenous fat emulsion (Lipomul I. V.) has recently become available for clinical use. Utilizing a 15% emulsion of cottonseed oil with soybean phosphatides and Pleuronic F-68 ( oxyethyleneoxypropylene polymer) as stabilizers, it is prepared with 4% dextrose in water as a vehicle. 1 A preliminary report from the surgical service of the Illinois Research and Educational Hospitals 2 indicated that this improved fat emulsion was sufficiently free of side-effects to make it safe for routine clinical use. The most prominent reactions noted in this study were a transient minor hypertensive response in 48% of infusions and a transient temperature elevation in 1.6% of patients. Studies on this preparation have since been extended to include an additional 95 patients, who have received a total of 580 units of intravenous fat for an average consumption of 6 units per patient. Each unit contained 500 or 600 cc. of fat emulsion, depending on","PeriodicalId":6876,"journal":{"name":"A.M.A. archives of surgery","volume":"8 1","pages":"851-5"},"PeriodicalIF":0.0000,"publicationDate":"1959-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Clinical use of intravenous fat in surgical patients.\",\"authors\":\"W. Marshall\",\"doi\":\"10.1097/00006534-195910000-00030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"An intravenous fat emulsion (Lipomul I. V.) has recently become available for clinical use. Utilizing a 15% emulsion of cottonseed oil with soybean phosphatides and Pleuronic F-68 ( oxyethyleneoxypropylene polymer) as stabilizers, it is prepared with 4% dextrose in water as a vehicle. 1 A preliminary report from the surgical service of the Illinois Research and Educational Hospitals 2 indicated that this improved fat emulsion was sufficiently free of side-effects to make it safe for routine clinical use. The most prominent reactions noted in this study were a transient minor hypertensive response in 48% of infusions and a transient temperature elevation in 1.6% of patients. Studies on this preparation have since been extended to include an additional 95 patients, who have received a total of 580 units of intravenous fat for an average consumption of 6 units per patient. Each unit contained 500 or 600 cc. of fat emulsion, depending on\",\"PeriodicalId\":6876,\"journal\":{\"name\":\"A.M.A. archives of surgery\",\"volume\":\"8 1\",\"pages\":\"851-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1959-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A.M.A. archives of surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/00006534-195910000-00030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A.M.A. archives of surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/00006534-195910000-00030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
摘要
静脉注射脂肪乳剂(Lipomul I. V.)最近已可用于临床。以15%的棉籽油与大豆磷脂和Pleuronic F-68(氧乙烯-氧丙烯聚合物)为稳定剂,以4%的葡萄糖水溶液为载体制备。一份来自伊利诺斯州研究和教育医院外科部门的初步报告表明,这种改良的脂肪乳剂完全没有副作用,可以安全用于临床常规使用。本研究中最突出的反应是48%的输注患者出现短暂的轻微高血压反应,1.6%的患者出现短暂的体温升高。对这种制剂的研究已经扩展到另外95名患者,他们接受了总计580单位的静脉注射脂肪,平均每名患者消耗6单位。每个单位含有500或600毫升的脂肪乳液,取决于
Clinical use of intravenous fat in surgical patients.
An intravenous fat emulsion (Lipomul I. V.) has recently become available for clinical use. Utilizing a 15% emulsion of cottonseed oil with soybean phosphatides and Pleuronic F-68 ( oxyethyleneoxypropylene polymer) as stabilizers, it is prepared with 4% dextrose in water as a vehicle. 1 A preliminary report from the surgical service of the Illinois Research and Educational Hospitals 2 indicated that this improved fat emulsion was sufficiently free of side-effects to make it safe for routine clinical use. The most prominent reactions noted in this study were a transient minor hypertensive response in 48% of infusions and a transient temperature elevation in 1.6% of patients. Studies on this preparation have since been extended to include an additional 95 patients, who have received a total of 580 units of intravenous fat for an average consumption of 6 units per patient. Each unit contained 500 or 600 cc. of fat emulsion, depending on